Stock Detail
CADENCE PHARMACEUTICALS INC
CADX @ Yahoo Finance | CADX Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $3.79 | $3.84 | $0.03 | 0.80% | 0.00 | $3.76 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $3.74 | $3.74 | 1.89M | 241.1M | 295,631 | -2.77 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 3.89 | 3.84 | 3.79 | 3.74 | 3.69 |
Stock Profile
Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the in-licensing, development, and commercialization of product candidates principally for use in the hospital setting in the United States and Europe. It has two Phase III products in development, including IV APAP for the treatment of acute pain and fever; and Omigard for the prevention of intravascular catheter-related infections. Cadence Pharmaceuticals, formerly known as Strata Pharmaceuticals, Inc., was founded in 2004 and is headquartered in San Diego, California.